Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has public registry information. It focuses on depression and currently lists study information in the United States.
In Belmont
This study is completed. It focuses on depression and currently lists study information in the United States.
In BelmontThis study is active but not recruiting. It focuses on bipolarity and currently lists study information in the United States.
In Belmont
This study was terminated in Canada. It is testing Low-Dose Adjunctive Aripiprazole in the Treatment of Depression for depression in bipolarity.
In MontrealThis study is active but not recruiting. It focuses on bipolarity and currently lists study information in the United States.
In BostonThis study is completed. It focuses on bipolarity and currently lists study information in Turkey.
In ElâzığThis study is completed. It focuses on bipolarity and currently lists study information in Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, and the United States.
Multiple locations, including BirminghamThis study is completed. It focuses on bipolarity and currently lists study information in Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, and the United States.
Multiple locations, including Little RockThis study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, Germany, India, Poland, Romania, Russian Federation, South Africa, Ukraine, and the United States.
Multiple locations, including Little RockThis study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, India, Romania, Russian Federation, South Africa, Ukraine, and the United States.
Multiple locations, including EscondidoThis study is completed. It focuses on bipolarity and currently lists study information in Canada.
In VancouverThis study is completed. It focuses on schizophrenia and currently lists study information in Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, and Ukraine.
Multiple locations, including KelownaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.